Literature DB >> 18929696

Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography.

Atsushi Tanaka1, Toshio Imanishi, Hironori Kitabata, Takashi Kubo, Shigeho Takarada, Hideaki Kataiwa, Akio Kuroi, Hiroto Tsujioka, Takashi Tanimoto, Nobuo Nakamura, Masato Mizukoshi, Kumiko Hirata, Takashi Akasaka.   

Abstract

The aim of this study was to investigate the distribution and frequency of thin-capped fibroatheromas (TCFAs) within the entire length of culprit coronary arteries in patients with acute coronary syndrome. Our population was drawn from 43 consecutive patients with acute coronary syndrome (with or without ST-segment elevation) who underwent optical coherence tomography to visualize the entire culprit coronary artery using a nonocclusive optical coherence tomographic technique. Patients were categorized divided into a TCFA group or a no-TCFA group on the basis of the optical coherence tomographic findings. There were no differences in baseline characteristics or angiographic findings between the 2 groups. High-sensitive C-reactive protein in the TCFA group was significantly higher than in the no-TCFA group (median 3.3 mg/L, interquartile 3.1, vs 1.7 mg/L, interquartile 2.2, p = 0.03). Plaque rupture was found in 28 patients (65%) and multiple plaque ruptures in 5 patients (12%). Optical coherence tomogram revealed 21 TCFAs in 18 patients (42%). Multiple TCFAs were found in the same vessel in 3 patients (7%). The distribution of TCFAs in the right coronary arteries of our subject population was relatively even (proximal 2 [12%], mid 5 [29%], distal 3 [18%], p = 0.42), whereas TCFAs in the left anterior descending artery were common in proximal sites (proximal 6 [27%], mid 2 [9%], distal 0, p = 0.018). In conclusion, the use of optical coherence tomography to look for TCFAs and identify their distribution when combined with C-reactive protein may contribute to forming a strategy for preventing impending coronary events.

Entities:  

Mesh:

Year:  2008        PMID: 18929696     DOI: 10.1016/j.amjcard.2008.05.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  Multimodality cardiovascular molecular imaging technology.

Authors:  Matthew O'Donnell; Elliot R McVeigh; H William Strauss; Atsushi Tanaka; Brett E Bouma; Guillermo J Tearney; Michael A Guttman; Ernest V Garcia
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

2.  Diagnosis of Thin-Capped Fibroatheromas in Intravascular Optical Coherence Tomography Images: Effects of Light Scattering.

Authors:  Jennifer E Phipps; Taylor Hoyt; Deborah Vela; Tianyi Wang; Joel E Michalek; L Maximilian Buja; Ik-Kyung Jang; Thomas E Milner; Marc D Feldman
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

3.  Label-free imaging of atherosclerotic plaques using third-harmonic generation microscopy.

Authors:  David M Small; Jason S Jones; Irwin I Tendler; Paul E Miller; Andre Ghetti; Nozomi Nishimura
Journal:  Biomed Opt Express       Date:  2017-12-13       Impact factor: 3.732

Review 4.  The diagnostic value of intracoronary optical coherence tomography.

Authors:  E Regar; J Ligthart; N Bruining; G van Soest
Journal:  Herz       Date:  2011-08       Impact factor: 1.443

Review 5.  What have we learned about plaque rupture in acute coronary syndromes?

Authors:  So-Yeon Choi; Gary S Mintz
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 6.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.

Authors:  Armin Arbab-Zadeh; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2015-01-16       Impact factor: 24.094

Review 7.  Intracoronary optical coherence tomography: a comprehensive review clinical and research applications.

Authors:  Hiram G Bezerra; Marco A Costa; Giulio Guagliumi; Andrew M Rollins; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2009-11       Impact factor: 11.195

8.  Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients.

Authors:  Micheli Zanotti Galon; Zhao Wang; Hiram G Bezerra; Pedro Alves Lemos; Audrey Schnell; David L Wilson; Andrew M Rollins; Marco A Costa; Guilherme F Attizzani
Journal:  Catheter Cardiovasc Interv       Date:  2014-10-04       Impact factor: 2.692

Review 9.  Prediction of cardiovascular outcomes by imaging coronary atherosclerosis.

Authors:  Faraz Pathan; Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

10.  Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.

Authors:  Stephen J Nicholls; Steven E Nissen; Francesco Prati; Stephan Windecker; Yu Kataoka; Rishi Puri; Thomas Hucko; Helina Kassahun; Jason Liao; Ransi Somaratne; Julie Butters; Giuseppe Di Giovanni; Stephen Jones; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.